Home » Topics » Conferences

Conferences
RSS

Alosetron emerging as safe and effective treatment for IBS in female patients

May 21, 1998

NO-releasing NSAID protects against gastric mucosal damage: in vitro and in vivo studies

May 21, 1998

IRFI-117, an adenosine A1 antagonist for oral or i.v. dosing

May 21, 1998

NO-NSAIDs retain antiinflammatory/analgesic potency, with fewer GI side effects

May 20, 1998

DEHOP phase II data discussed at Digestive Disease Week

May 20, 1998

S-Nitrosocaptopril combines NO-donor and ACE-inhibitor effects in a single molecule

May 20, 1998

Profile of eplerenone, a novel aldosterone antagonist from Searle

May 20, 1998

DISC HSV reported to be safe and immunogenic in phase I trials

May 20, 1998

Helicase-primase, an enzyme target for the design of new antiviral agents

May 19, 1998

IRL-3630: a bifunctional ET antagonist for respiratory ailments

May 12, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...